Jove
Visualize
Contact Us

Related Concept Videos

The Proteasome02:18

The Proteasome

10.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.1K
The Proteasome01:13

The Proteasome

1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome02:18

The Proteasome

4.5K
4.5K
The Proteasome Structure01:17

The Proteasome Structure

1.6K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
1.6K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

8.4K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.4K
tRNA Activation02:26

tRNA Activation

22.7K
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
22.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemical Induction of MYC Protein Degradation via MYC-MAX Disruption and 20S Proteasome Activation.

ACS chemical biology·2026
Same author

Recent Advancements in 20S Proteasome Enhancement: Degradation of Undruggable Targets.

ACS medicinal chemistry letters·2025
Same author

Tungsten-Enabled Diels-Alder Cycloaddition and Cycloreversion of Arenes and Alkynes: Divergent Synthesis of Highly Functionalized Barrelenes and Arenes.

Journal of the American Chemical Society·2025
Same author

Photoenzymatically-induced asymmetric hydroarylation of alkenes with (hetero)aryl halides.

Chemical communications (Cambridge, England)·2025
Same author

A Tetrazine-Based Synthesis for Accessing Underutilized Aza-Indole Analogues.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Same author

Short and High-Yielding Synthesis of a Minimalist Diazirine-Alkyne Photo-Cross-Linker and Photoaffinity Labeling Derivatives.

ACS omega·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 21, 2026

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain
09:25

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain

Published on: May 21, 2019

7.2K

Proteasome Activation to Combat Proteotoxicity.

Corey L Jones1, Jetze J Tepe2

  • 1Department of Chemistry; Michigan State University, East Lansing, MI 48824, USA.

Molecules (Basel, Switzerland)
|August 8, 2019
PubMed
Summary

Aging cells accumulate damaged proteins, driving neurodegenerative diseases like Alzheimer's. Boosting proteasome function offers a promising therapeutic strategy by clearing these toxic protein aggregates and intrinsically disordered proteins (IDPs).

Keywords:
IDPactivationaggregatesenhancementintrinsically disordered proteinsneurodegenerative diseaseoxidative damageproteasomeproteotoxic

More Related Videos

Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach
09:57

Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach

Published on: December 17, 2016

7.0K
Assaying Proteasomal Degradation in a Cell-free System in Plants
07:43

Assaying Proteasomal Degradation in a Cell-free System in Plants

Published on: March 26, 2014

15.0K

Related Experiment Videos

Last Updated: Jan 21, 2026

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain
09:25

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain

Published on: May 21, 2019

7.2K
Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach
09:57

Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach

Published on: December 17, 2016

7.0K
Assaying Proteasomal Degradation in a Cell-free System in Plants
07:43

Assaying Proteasomal Degradation in a Cell-free System in Plants

Published on: March 26, 2014

15.0K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Neuroscience

Background:

  • Loss of proteome fidelity results in accumulation of misfolded and oxidatively damaged proteins, hallmarks of cellular aging.
  • These protein aggregates are implicated in neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, and ALS.
  • Restoring proteostasis by enhancing proteasome function is a key therapeutic strategy for proteotoxic pathologies.

Purpose of the Study:

  • To review protein disorders and their susceptibility to proteasomal degradation.
  • To examine the proteasome, including recent structural data.
  • To summarize small molecule proteasome activators for therapeutic development.

Main Methods:

  • Literature review of protein aggregation and proteasome function.
  • Analysis of recent structural data on the proteasome.
  • Compilation of known small molecule proteasome activators.

Main Results:

  • Protein misfolding and aggregation are central to aging and neurodegeneration.
  • The proteasome targets intrinsically disordered proteins (IDPs) and damaged species.
  • Emerging structural data provides insights into proteasome mechanisms.
  • Several small molecule proteasome activators have been identified.

Conclusions:

  • Enhancing proteasome activity is a viable therapeutic approach for neurodegenerative diseases.
  • Understanding protein degradation pathways is crucial for developing effective treatments.
  • Further research into proteasome activators may yield novel therapeutic interventions.